8-K/A

AMENDMENT NO. 1 TO CURRENT REPORT

Company: OptimizeRx Corp
Filed: December 18, 2019
Period of Report: October 4, 2019
Accession Number: 0001213900-19-026477

View Document ↗ View on SEC.gov ↗